• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical importance of intraperitoneal pressure in peritoneal dialysis and measures to counteract its effect on net ultrafiltration.

作者信息

Flessner M F

机构信息

Nephrology Unit, University of Rochester, New York, USA.

出版信息

Adv Perit Dial. 1999;15:45-52.

PMID:10682071
Abstract

Experiments in animals and in humans have shown that fluid loss from the peritoneal cavity to the body increases with large increments in the intraperitoneal hydrostatic pressure (IPP). We have demonstrated previously that much of this fluid loss occurs to the abdominal wall and is driven by the hydrostatic pressure gradient (i.p. pressure-skin pressure) that develops across the wall whenever therapeutic or pathologic volumes of fluid reside in the cavity. We hypothesized that eliminating the pressure difference across the wall by applying an equal and opposite pressure [abdominal counterpressure (ACP)] would decrease fluid movement into the wall and decrease fluid movement from the cavity. In addition, we hypothesized that net ultrafiltration or net fluid recovery would increase with ACP. To address these hypotheses, we dialyzed rats for 3 hours in the supine position at constant levels of IPP (4, 6, and 8 cmH2O) with isotonic or hypertonic dialysis solutions containing a protein marker of fluid movement. We measured total fluid loss, fluid marker concentration in the abdominal wall, and lymph flow. In separate animals, we repeated the experiments with ACP. Total fluid loss as determined by protein clearance and fluid marker deposition in the abdominal wall was decreased in all experiments. Lymph flow was unchanged by ACP. While ACP increased the net fluid recovery in isotonic dialysis, no change was observed in the hypertonic case. Analogous experiments were carried out in six dialysis patients with or without ACP during a 4-hour dialysis with 1.5% dextrose solution performed in the supine position at i.p. hydrostatic pressure of 4-6 cmH2O. No significant difference was noted in the measured net ultrafiltration between control and ACP studies. We conclude that the careful application of ACP does decrease fluid loss (particularly to the abdominal wall) during isotonic or hypertonic dialysis in the rat. However, ACP results in improved fluid recovery only with isotonic dialysis in rats and has no effect on the recovery of fluid during peritoneal dialysis in humans.

摘要

相似文献

1
Clinical importance of intraperitoneal pressure in peritoneal dialysis and measures to counteract its effect on net ultrafiltration.
Adv Perit Dial. 1999;15:45-52.
2
Pressure threshold for fluid loss from the peritoneal cavity.腹膜腔液体流失的压力阈值。
Am J Physiol. 1996 Feb;270(2 Pt 2):F377-90. doi: 10.1152/ajprenal.1996.270.2.F377.
3
Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.透明质酸可防止因腹膜透析液填充量增加而导致的净超滤减少。
Kidney Int. 1998 Feb;53(2):496-502. doi: 10.1046/j.1523-1755.1998.00773.x.
4
APD: clinical measurement of the maximal acceptable intraperitoneal volume.腹腔内压:最大可接受腹腔容积的临床测量值。
Adv Perit Dial. 1994;10:63-7.
5
Intraperitoneal pressure, peritoneal permeability and volume of ultrafiltration in CAPD.持续性非卧床腹膜透析中的腹腔内压力、腹膜通透性及超滤量
Adv Perit Dial. 1992;8:22-5.
6
Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions.不同载体溶液腹腔内注射紫杉醇的药代动力学及组织分布
Cancer Chemother Pharmacol. 2003 Nov;52(5):405-10. doi: 10.1007/s00280-003-0680-2. Epub 2003 Jul 23.
7
Hydrostatic intraperitoneal pressure in children on peritoneal dialysis: practical implications. An 18-month clinical experience.儿童腹膜透析患者的腹腔内静水压:实际意义。18个月的临床经验。
Adv Perit Dial. 1994;10:294-6.
8
Monoclonal antibody delivery to intraperitoneal tumors in rats: effects of route of administration and intraperitoneal solution osmolality.单克隆抗体向大鼠腹腔肿瘤的递送:给药途径和腹腔内溶液渗透压的影响。
Cancer Res. 1994 Aug 15;54(16):4376-84.
9
Effect of increased dialysate fill volume on peritoneal fluid and solute transport.增加透析液填充量对腹膜液和溶质转运的影响。
Kidney Int. 1997 Oct;52(4):1068-76. doi: 10.1038/ki.1997.430.
10
Routine measurement of hydrostatic intraperitoneal pressure.腹腔内静水压的常规测量。
Adv Perit Dial. 1992;8:108-12.